Hjem › Dermatomyositt › Ohio
Kliniske studier for Dermatomyositt i Ohio
5 studier for Dermatomyositt søker deltakere på steder i Ohio.
Byer i Ohio
Offisiell studietekst (engelsk)
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Research Site, Cleveland
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06455449Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT03816345A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- Cleveland Clinic, Cleveland
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT05895786Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
- Cincinnati Children's Hospital Medical Center, Cincinnati
RekruttererFase 1/2
Alder 12 og eldre · Alle kjønn · Oppdatert 27. jul. 2026 · NCT07089121Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis
- Cleveland Clinic, Cleveland
RekruttererFase 2
Alder 18 til 89 · Alle kjønn · Oppdatert 8. okt. 2025 · NCT06857240Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.